Want to see KR:200130 full AI Analyst Report?

KolmarBNH Co., Ltd. (200130) Price & Analysis

― Followers

200130 Stock Chart & Stats

$7830.00

$530.00(7.26%)

Oct 29, 2026

―

Day’s Range― - ―

52-Week Range$7,220.00 - $15,150.00

Previous CloseN/A

VolumeN/A

Average Volume (3M)30.70K

Market Cap

₩216.54B

Enterprise Value$251.14B

Total Cash (Recent Filing)₩121.74B

Total Debt (Recent Filing)₩150.36B

Price to Earnings (P/E)―

Beta0.32

Next Earnings

Mar 22, 2027

EPS EstimateN/A

Next Dividend Ex-DateN/A

Dividend Yield0.77%

Share Statistics

EPS (TTM)-69.01

Shares Outstanding28,775,558

10 Day Avg. Volume33,721

30 Day Avg. Volume30,704

Financial Highlights & Ratios

PEG Ratio0.08

Price to Book (P/B)1.23

Price to Sales (P/S)0.76

P/FCF Ratio27.90

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price TargetN/A

Price Target UpsideN/A

Rating ConsensusN/A

Number of Analyst Covering0

EPS Forecast (FY)910.3

Revenue Forecast (FY)₩713.40B

Bulls Say, Bears Say

Bulls Say

ODM/OEM Business ModelKolmarBNH’s ODM/OEM model combines product formulation, development, and manufacturing for client brands, creating an integrated service offering. Supporting multiple supplement formats and customer requirements can deepen commercial relationships and provide a durable platform for recurring outsourced production demand.

Improving Cash GenerationPositive operating cash flow and the return to positive free cash flow improve the company’s ability to fund operations and investment internally. Although the recovery must prove durable, the 2025 improvement provides a stronger cash-generation base than the preceding period of repeated free-cash-flow deficits.

Moderate LeverageDebt of approximately 0.61 times equity indicates leverage remains moderate rather than excessive, while substantial equity relative to assets provides a buffer against operating volatility. This balance-sheet position should preserve some financial flexibility as management works through weaker profitability.

Bears Say

Revenue And Profitability DeclineThe combination of lower revenue and a return to net losses shows that recent earnings power has weakened materially from 2023–2024. Stable gross margin has not prevented overall profitability deterioration, reducing internal funding capacity and making future earnings less predictable.

Unproven Free-Cash-Flow RecoveryThe latest free-cash-flow improvement is encouraging but follows several consecutive deficit years, so it does not yet establish a durable conversion trend. Moderate cash coverage versus debt means sustained operating cash inflows remain important for funding investment and reducing financial strain.

Affiliate Debt GuaranteesGuaranteeing affiliate borrowing adds contingent liabilities beyond KolmarBNH’s direct operating obligations and links capital exposure to an affiliated entity’s financing. While the filing does not report a current loss, these commitments could reduce financial flexibility if the affiliate’s repayment capacity weakens.

KolmarBNH Co., Ltd. News

KolmarBNH Posts Surging Profit on Provisional Q3 Results Despite Softer Sales

The latest update is out from KolmarBNH Co., Ltd. ( ($KR:200130) ). KolmarBNH reported provisional third-quarter 2026 separate...

2d ago

KolmarBNH Discloses Group Status and Extends ₩7.92 Billion Debt Guarantees to Affiliate

KolmarBNH Co., Ltd. ( ($KR:200130) ) has issued an announcement. KolmarBNH has filed its quarterly disclosure on its...

2M ago

200130 FAQ

What was KolmarBNH Co., Ltd.’s price range in the past 12 months?

KolmarBNH Co., Ltd. lowest stock price was $7220.00 and its highest was $15150.00 in the past 12 months.

What is KolmarBNH Co., Ltd.’s market cap?

KolmarBNH Co., Ltd.’s market cap is ₩216.54B.

When is KolmarBNH Co., Ltd.’s upcoming earnings report date?

KolmarBNH Co., Ltd.’s upcoming earnings report date is Mar 22, 2027 which is in 143 days.

How were KolmarBNH Co., Ltd.’s earnings last quarter?

KolmarBNH Co., Ltd. released its earnings results on Aug 14, 2026. The company reported $244.981 earnings per share for the quarter.

Is KolmarBNH Co., Ltd. overvalued?

According to Wall Street analysts KolmarBNH Co., Ltd.’s price is currently Undervalued. Get more investment ideas with TipRanks Premium

Does KolmarBNH Co., Ltd. pay dividends?

KolmarBNH Co., Ltd. pays a Semiannually dividend of $75 which represents an annual dividend yield of 0.77%. See more information on KolmarBNH Co., Ltd. dividends here

What is KolmarBNH Co., Ltd.’s EPS estimate?

KolmarBNH Co., Ltd.’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does KolmarBNH Co., Ltd. have?

KolmarBNH Co., Ltd. has 28,775,558 shares outstanding.

What happened to KolmarBNH Co., Ltd.’s price movement after its last earnings report?

KolmarBNH Co., Ltd. reported an EPS of $244.981 in its last earnings report. Following the earnings report the stock price went up 7.26%.

Which hedge fund is a major shareholder of KolmarBNH Co., Ltd.?

Currently, no hedge funds are holding shares in KR:200130

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Company Description

KolmarBNH Co., Ltd.

Kolmar BNH Co Ltd is a South Korean enterprise specializing in the production and supply of diverse pharmaceutical products, such as medicinal compounds, antibiotics, and biologics. Beyond its pharmaceutical core, the company also develops health-enhancing foods designed to bolster immunity. Additionally, Kolmar BNH operates a phytochemical segment that manufactures cosmetic and functional beauty ingredients, primarily leveraging natural extracts.